Trials / Recruiting
RecruitingNCT05820672
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
A US Multi-center, Prospective, Non-interventional, Long Term, Effectiveness and Safety Study of Patients Treated With SKYTROFA (Lonapegsomatropin)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 900 (estimated)
- Sponsor
- Ascendis Pharma Endocrinology Division A/S · Industry
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care
Detailed description
Patients will be treated according to routine clinical practice, and no additional visits, examinations or tests will be required beyond those performed as part of routine clinical practice except for COAs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2023-03-20
- Primary completion
- 2033-03-01
- Completion
- 2033-03-01
- First posted
- 2023-04-20
- Last updated
- 2026-02-04
Locations
27 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05820672. Inclusion in this directory is not an endorsement.